Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple microbial cellular components refers to the diverse array of structural and functional molecules within microorganisms—including bacteria, viruses, and fungi—that serve as targets for broad-spectrum antimicrobial agents (StatPearls, 2023). Unlike targeted antibiotics that inhibit specific metabolic pathways, agents hitting multiple components typically exert rapid, non-specific effects such as the denaturation of proteins, disruption of lipid membranes, and oxidation of nucleic acids (Journal of Hospital Infection, 2004). This multi-target approach is the hallmark of antiseptics, disinfectants, and certain topical anti-infectives, making it difficult for microbes to develop resistance (CDC, 2008). These agents are critical in clinical practice for surgical site preparation, wound management, and environmental decontamination to prevent the spread of infectious diseases (NIH, 2022). Common examples of such agents include povidone-iodine, chlorhexidine, and various alcohols, which are used to reduce microbial load on skin and surfaces (PubChem, 2023). Because these mechanisms can also affect host cells, their application is primarily restricted to topical or external use to avoid systemic toxicity (StatPearls, 2023). The lack of specificity allows these agents to remain effective against a wide range of pathogens, including multi-drug resistant organisms.
Drugs targeting multiple microbial cellular components typically act through non-specific mechanisms such as protein denaturation, membrane disruption, and oxidative damage to nucleic acids and enzymes (StatPearls, 2023; Journal of Hospital Infection, 2004).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple microbial cellular components.